

Velsera connects healthcare and life sciences to reveal the true promise of precision medicine—a continuous flow of knowledge between researchers, scientists and clinicians around the world, creating insights that radically improve human health.
We power this ecosystem of insight with data made actionable by AI and technology solutions that accelerate R&D, democratize omics and provide bedside analytics to improve patient outcomes.
Stay in the loop with product and service updates as we create a new era of medicine powered by Velsera—the precision engine company.
When knowledge flows freely between the clinical realm and R&D, a network effect arises: research discoveries translate to diagnostics, and patient outcomes inform new breakthroughs.
This virtuous cycle drives what we call the value loop—iterative learning and technology-enabled solutions that support all points in the healthcare continuum.
Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.
We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.
We equip researchers and clinicians with relevant information for diagnosis, therapy selection, monitoring and response prediction.
Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.
We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.
Our broad expertise integrating diverse data sets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.
Comprehensive clinical and research omic knowledgebases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.
These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics — closing the loop and setting the standard for omics-based healthcare.
Our technology manages and orchestrates the flow of patient samples using cutting-edge tracking and tracing to guard the quality of data and maximize its use for research and diagnostics.
We apply AI and machine learning software to automate the analysis of multiple testing modalities, producing results that are qualitative, accurate and amenable for clinical annotation and reporting.
We equip researchers and clinicians with relevant information for diagnosis, therapy selection, monitoring and response prediction.
Our teams curate a continuously growing knowledge base that effectively democratizes omics, providing unparalleled access to data and clinical information for accurate and up-to-date reporting.
We aggregate clinical information and its underlying raw data to provide a multi-omic view that enhances data from clinical trials and research studies, leveraging insight from both sides of the loop.
Our broad expertise integrating diverse data sets provides the tools and services needed to make data work together, unlocking unprecedented insights that make joint discovery possible.
Comprehensive clinical and research omic knowledgebases can be accessed independently or in conjunction with Velsera experts, with AI and machine learning performing intelligent, deep analyses that yield actionable insights.
These data-driven insights drive precision R&D, improve drug discovery and clinical trials as well as inform routine diagnostics — closing the loop and setting the standard for omics-based healthcare.
Velsera unites established, leading companies from healthcare and life sciences to advance and accelerate the work of both domains. All companies will remain actively engaged with existing customers, enhance current offerings, accelerate new offerings and bring integrated solutions to market as the leading provider of global omics and insights.
The vision for Velsera is supported by Summa Equity, a purpose-driven investment firm advancing precision health through data-driven solutions.
Keep up with new products, services and enhancements to the offerings of our constituent companies as we become Velsera—the precision engine company.